Oxford Cannabinoid Technologies (OCTP) Stock Chart & Stock Price History GBX 0.12 -0.01 (-4.17%) (As of 06/5/2024) Add Compare Share Share Chart Stock AnalysisChartInsider Trades Oxford Cannabinoid Technologies Stock Price Performance 5 Day Performance0.00%1 Month Performance0.00%3 Month Performance0.00%6 Month Performance-36.11%Year-To-Date Performance-81.60%1 Year Performance-82.31% Receive OCTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Cannabinoid Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address “Trump Trades” You’ve Got to Make (Ad)These Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to pop now that Donald Trump has been re-electedClaim your copy before they move OCTP Stock Chart for Friday, November, 22, 2024 OCTP Chart by TradingView Oxford Cannabinoid Technologies Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/21/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/20/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/19/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/18/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/15/2024N/AGBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/13/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million Get the Latest News and Ratings for OCTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oxford Cannabinoid Technologies and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024N/AGBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/08/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/07/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/06/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/05/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/04/2024N/AGBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million11/01/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/31/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/30/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/29/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/28/2024N/AGBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/25/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/24/2024N/AGBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/22/2024GBX 0.12GBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million10/21/2024N/AGBX 0.12GBX 0.20GBX 0.1211.40 million shs£1.25 million Related Companies Fusion Antibodies Stock Price Chart Oxford BioDynamics Stock Price Chart BSF Enterprise Stock Price Chart Destiny Pharma Stock Price Chart Theracryf Stock Price Chart ValiRx Stock Price Chart Physiomics Stock Price Chart Ovoca Bio Stock Price Chart Nuformix Stock Price Chart Oxford Nanopore Technologies Stock Price Chart Receive OCTP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Cannabinoid Technologies and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OCTP) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Cannabinoid Technologies Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Cannabinoid Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
